900000000000526001: REPLACED BY association reference set (foundation metadata concept)

SNOMED CT Concept\SNOMED CT Model Component\Foundation metadata concept (foundation metadata concept)\Reference set\Association type\Historical association reference set (foundation metadata concept)\REPLACED BY association reference set (foundation metadata concept)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module

900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)

900000000001157018 REPLACED BY association reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
REPLACED BY association reference set (foundation metadata concept)	Is a	Historical association reference set (foundation metadata concept)	true	Inferred relationship	Some

Members	targetComponentId
Chloroxylenol	Chloroxylenol (substance)
Chlorpheniramine 2mg/ibuprofen 200mg/pseudoephedrine 30mg caplet	Product containing precisely chlorphenamine maleate 2 milligram and ibuprofen 200 milligram and pseudoephedrine hydrochloride 30 milligram/1 each conventional release oral tablet (clinical drug)
Chlorpheniramine 2mg/ibuprofen 200mg/pseudoephedrine 30mg conventional release oral tablet	Product containing precisely chlorphenamine maleate 2 milligram and ibuprofen 200 milligram and pseudoephedrine hydrochloride 30 milligram/1 each conventional release oral tablet (clinical drug)
Chlorpheniramine maleate	Product containing chlorphenamine (medicinal product)
Chlorpheniramine maleate + methscopolamine nitrate + pseudoephedrine hydrochloride 8mg/2.5mg/120mg m/r tablet	Product containing only chlorphenamine and methscopolamine and pseudoephedrine in oral dose form (medicinal product form)
Chlorpheniramine maleate + methscopolamine nitrate + pseudoephedrine hydrochloride 8mg/2.5mg/120mg prolonged-release oral tablet	Product containing only chlorphenamine and methscopolamine and pseudoephedrine in oral dose form (medicinal product form)
Chlorpheniramine maleate + pseudoephedrine hydrochloride	Product containing chlorphenamine and pseudoephedrine (medicinal product)
Chlorpheniramine maleate+phenylephrine hydrochloride+phenyltoloxamine citrate 4mg/20mg/50mg m/r capsule	Chlorphenamine and phenylephrine and phenyltoloxamine only product in oral dose form
Chlorpheniramine maleate+phenylephrine hydrochloride+phenyltoloxamine citrate 4mg/20mg/50mg prolonged-release oral capsule	Chlorphenamine and phenylephrine and phenyltoloxamine only product in oral dose form
Chlorpromazine hydrochloride 10mg/5mL syrup	Chlorpromazine hydrochloride 2 mg/mL oral solution
Chlorpromazine hydrochloride 150mg m/r capsule	Product containing only chlorpromazine in oral dose form (medicinal product form)
Chlorpromazine hydrochloride 150mg prolonged-release oral capsule	Product containing only chlorpromazine in oral dose form (medicinal product form)
Chlorpromazine hydrochloride 30mg m/r capsule	Product containing only chlorpromazine in oral dose form (medicinal product form)
Chlorpromazine hydrochloride 30mg prolonged-release oral capsule	Product containing only chlorpromazine in oral dose form (medicinal product form)
Chlorpromazine hydrochloride 50mg/5mL syrup	Product containing precisely chlorpromazine hydrochloride 10 milligram/1 milliliter conventional release oral solution (clinical drug)
Chlorpromazine hydrochloride 75mg m/r capsule	Product containing only chlorpromazine in oral dose form (medicinal product form)
Chlorpromazine hydrochloride 75mg prolonged-release oral capsule	Product containing only chlorpromazine in oral dose form (medicinal product form)
Chlorprothixene overdose	Chlorprothixene overdose (disorder)
Chlortetracycline hydrochloride 3% ointment	Product containing precisely chlortetracycline 30 milligram/1 gram conventional release cutaneous ointment (clinical drug)
Cholelithiasis NOS	Biliary calculus
Cholelithiasis NOS	Biliary calculus
Cholesteatoma with complications	Cholesteatoma
Cholesterol analyte	Cholesterol
Cholesterol reduction program - declined	Cholesterol reduction programme declined
Cholestyramine + sucrose	Product containing colestyramine (medicinal product)
Cholestyramine 4g powder	Colestyramine 4 g powder for oral suspension sachet
Cholestyramine 4g suspension	Colestyramine 4 g powder for oral suspension sachet
Cholestyramine 4g/unit powder	Colestyramine 4 g powder for oral suspension sachet
Cholestyramine 4g/unt powder	Colestyramine 4 g powder for oral suspension sachet
Cholestyramine+aspartame	Product containing colestyramine (medicinal product)
Cholestyramine+aspartame 4g/sachet powder	Colestyramine 4 g powder for oral suspension sachet
Choline salicylate 870mg/5ml liquid	Product containing precisely choline salicylate 87 milligram/1 gram conventional release oromucosal gel (clinical drug)
Choline salicylate+glycerol 20%/12.6% ear drops	Product containing precisely choline 200 milligram/1 milliliter and glycerol 126 milligram/1 milliliter conventional release ear solution (clinical drug)
Choline theophyllinate allergy	Allergy to theophylline (finding)
Chondrocalcinosis due to dicalcium phosphate crystals, NOS	Chondrocalcinosis due to dicalcium phosphate crystals
Chondrocalcinosis due to dicalcium phosphate crystals, of other specified site	Chondrocalcinosis due to dicalcium phosphate crystals
Chondrocalcinosis due to dicalcium phosphate crystals, of unspecified site	Chondrocalcinosis due to dicalcium phosphate crystals
Chondrocyte cell	Chondrocyte (substance)
Chondrosarcoma - category	Chondrosarcoma
Chondrosarcoma, no International Classification of Diseases for Oncology subtype	Chondrosarcoma
Choriocarcinoma, no International Classification of Diseases for Oncology subtype	Choriocarcinoma (morphologic abnormality)
Choriogonadotropin alfa 10,000iu powder and solvent for injection solution ampule	Choriogonadotropin alfa only product in parenteral dose form
Choriogonadotropin alfa 10,000iu powder for conventional release solution for injection ampule	Choriogonadotropin alfa only product in parenteral dose form
Choriogonadotropin alfa 1500iu powder and solvent for injection solution ampule	Choriogonadotropin alfa only product in parenteral dose form
Choriogonadotropin alfa 1500iu powder for conventional release solution for injection ampule	Choriogonadotropin alfa only product in parenteral dose form
Choriogonadotropin alfa 2000iu powder and solvent for injection solution ampule	Choriogonadotropin alfa only product in parenteral dose form
Choriogonadotropin alfa 2000iu powder for conventional release solution for injection ampule	Choriogonadotropin alfa only product in parenteral dose form
Choriogonadotropin alfa 5000iu powder and solvent for injection solution ampule	Product containing only choriogonadotropin (medicinal product)
Choriogonadotropin alfa 5000iu powder for conventional release solution for injection ampule	Product containing only choriogonadotropin (medicinal product)
Choroid meningioma	Meningioma, chordoid (morphologic abnormality)
Choroid plexus papilloma, no International Classification of Diseases for Oncology subtype	Benign choroid plexus papilloma (morphologic abnormality)
Choroideremia co-occurrent with hypopituitarism	Choroideremia with deafness and obesity syndrome (disorder)
Chromic phosphate, p-32 15mCi injection suspension 10mL vial	Chromic phosphate (32-P) only product in parenteral dose form
Chromic phosphate, p-32 7.0mil/mL injection	Chromic phosphate (32-P) only product in parenteral dose form
Chromic phosphate[32P] 185MBq/mL injection	Chromic phosphate (32-P) only product in parenteral dose form
Chromic phosphate[32P] 185MBq/mL powder for injection solution vial	Chromic phosphate (32-P) only product in parenteral dose form
Chromobacterium fluviatile	Iodobacter fluviatilis
Chromobacterium lividum	Janthinobacterium lividum (organism)
Chromosomal anomalies NOS	Congenital chromosomal disease
Chromosomal anomalies NOS	Congenital chromosomal disease
Chromosome replaced with ring or dicentric	Ring chromosome
Chronic active type A viral hepatitis	Viral hepatitis, type A
Chronic aggressive type A viral hepatitis	Viral hepatitis, type A
Chronic angle-closure glaucoma	Chronic angle-closure glaucoma
Chronic antritis	Chronic maxillary sinusitis
Chronic cyclitis	Intermediate uveitis
Chronic cystitis - culture negative	Chronic cystitis
Chronic duodenal ulcer NOS	Chronic duodenal ulcer
Chronic duodenal ulcer NOS	Chronic duodenal ulcer
Chronic erythremia	Polycythemia vera
Chronic erythremia	Polycythemia vera (clinical)
Chronic erythremia	Polycythemia vera (clinical)
Chronic erythremia in remission	Polycythemia vera (clinical)
Chronic female pelvic peritonitis	Chronic inflammation of pelvic peritoneum (disorder)
Chronic gastric ulcer NOS	Chronic gastric ulcer
Chronic gastric ulcer NOS	Chronic gastric ulcer
Chronic glomerulonephritis associated with another disorder	Chronic glomerulonephritis
Chronic infection	Chronic infectious disease
Chronic iridocyclitis due to another disorder	Iridocyclitis
Chronic ischaemic heart disease NOS	Chronic ischemic heart disease (disorder)
Chronic ischemic heart disease NOS	Chronic ischemic heart disease (disorder)
Chronic kidney disease clinical management plan	Chronic kidney disease clinical management plan (record artifact)
Chronic kidney disease with osteoporosis	Osteoporosis due to chronic kidney disease (disorder)
Chronic laryngitis NOS	Chronic laryngitis
Chronic laryngitis NOS	Chronic laryngitis
Chronic latent schizophrenia	Schizotypal personality disorder
Chronic leukaemia NOS	Chronic leukemia
Chronic leukemia - category	Chronic leukemia (morphologic abnormality)
Chronic leukemia NOS	Chronic leukemia
Chronic liver disease NOS	Chronic liver disease
Chronic liver disease NOS	Chronic liver disease
Chronic lymphoid leukemia - category	B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma
Chronic lymphoproliferative disease	Lymphoproliferation of uncertain behavior (morphologic abnormality)
Chronic monocytic leukemia	Chronic myelomonocytic leukaemia
Chronic monocytic leukemia	Myeloid leukaemia
Chronic monocytic leukemia in remission	Myeloid leukemia in remission
Chronic multifocal osteomyelitis	Chronic nonbacterial osteomyelitis/chronic recurrent multifocal osteomyelitis
Chronic multifocal osteomyelitis	Chronic nonbacterial osteomyelitis/chronic recurrent multifocal osteomyelitis
Chronic myelogenous leukemia, BCR/ABL positive	Chronic myeloid leukemia (morphologic abnormality)
Chronic myelogenous leukemia, no International Classification of Diseases for Oncology subtype	Chronic myeloid leukemia (morphologic abnormality)
Chronic myeloid leukemia - category	Chronic myeloid leukemia (morphologic abnormality)

Start Previous Page 31 of 195 Next End

Reference Sets

Reference set descriptor

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
900000000001156010	REPLACED BY association reference set (foundation metadata concept)	en	Fully specified name	Active	Entire term case sensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)
900000000001157018	REPLACED BY association reference set	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)